3D printed medical devices can be designed for a particular patient, procedure or application, using digital models derived from medical imaging or other data. Their layer-by-layer production can also enable complex geometries and custom accessories. But the design flexibility of additive manufacturing does not remove the need for rigorous safety controls. Before a device is used, healthcare teams need to consider its intended purpose, patient risk, materials, cleaning and sterilization, and the quality of the manufacturing process.
These considerations apply whether printing takes place within a healthcare institution or a third party develops the device. A structured evaluation helps end-users understand what the device must do, how it will be reprocessed, and what evidence is needed to support its safe use.
Start with the intended use and patient risk
The first step is to define how the device will contact the patient and what it is intended to do. Under Spauldingās classification, a device is non-critical if it contacts intact skin, semi-critical if it contacts mucous membranes or non-intact skin, and critical if it enters sterile tissue, including the vascular system. Critical and semi-critical devices carry particular infection risks if they are not appropriately handled, cleaned and disinfected or sterilized.
A device may also combine components with different risk classifications. In that case, teams should identify the risks associated with each part rather than treating the whole assembly as having a single contact type. The intended use and design also inform the deviceās Health Canada risk class. The four classes range from Class I, the lowest risk, to Class IV, the highest. For example, external prosthetics are Class I, while cranial implants and heart valves are Class IV.
Risk classification is not simply a label. It informs decisions about materials, validation, reprocessing, testing and the potential consequences of device failure.
Decide whether the device is single-use or reusable
End-users should determine whether the device is intended for one use or for repeated use. Reusable devices require reprocessing instructions that can be carried out consistently. Some design features can make cleaning and disinfection or sterilization difficult, increasing the importance of assessing whether reuse is appropriate.
Features that may complicate reprocessing include:
- Long, narrow lumens or channels, including those less than 1 mm in diameter.
- Valves that cannot be disassembled, or instruments that cannot be opened for cleaning.
- Crevices, joints, hinges, ribbing or rough, irregular surfaces that can retain soil.
- Porous materials or surface structures that are difficult to access.
For a reusable device, teams should confirm that validated instructions cover every component and that the medical device reprocessing department can perform the required process. If a third party provides validation, the end-user should work with the reprocessing department to review and communicate the protocol.
Assess materials and validate reprocessing
Materials must be suitable for the intended use, including the deviceās classification and required biocompatibility. Assessment should account for the final, finished deviceānot only the raw printing material. Manufacturing may involve additives or other substances, and post-processing can affect the final product. Biocompatibility considerations therefore relate to the device as produced and prepared for use.
Cleaning, disinfection and sterilization instructions need to be validated for the deviceās material, manufacturing process and design. Validation should consider challenging features such as porosity, internal voids and residual manufacturing material. For a device printed from metal powder, for instance, cleaning validation should address whether loose powder particles can be removed.
Possible sources of validated instructions include the material manufacturer, a qualified third-party laboratory, orā for non-critical devices onlyādevelopment by a healthcare facility in consultation with its experts. Teams should also check whether existing equipment, products and protocols can support the required process.
Build a documented quality process
When a healthcare institution prints a medical device for use on its patients, it takes on the role of manufacturer. Outsourcing design or development to a third party shifts that role to the third party. Even where an institution does not distribute or sell devices outside its organization, its manufacturing activities are expected to meet applicable safety and quality requirements.
A documented quality process should describe the path from patient image acquisition and design through printing, post-processing and preparation of the finished device. A process flow diagram can help teams identify each stage, its parameters and its outputs. Documentation should specify relevant design inputs, critical dimensions and features, physical characteristics, and compatibility or fit with other equipment or devices.
The level of characterization and testing depends on the device and its risks. Relevant factors include whether it is an implant, instrument, load-bearing device, single-use or reusable product, or patient-matched design. Manufacturer instructions for printing and post-processing should be available and followed.
Device validation may need to address:
- Biocompatibility based on the nature of patient contact.
- Cleaning, disinfection or sterilization under appropriately challenging conditions.
- Removal of manufacturing residues to acceptable levels.
- Function and usability for the intended purpose.
- Reproducibility and consistency of the manufacturing process, particularly for higher-risk devices.
Device labels and records should provide enough information to identify and trace the product. Depending on the device, this can include a patient identifier, intended use, instructions and warnings, design version, batch information and an expiration date. Records should also describe the manufacturing method, process flow and post-processing steps.
Monitor performance after use
Quality oversight continues after a device enters use. Teams should monitor for performance problems such as wear or corrosion and for adverse effects, including material-related allergies or infection associated with inadequate reprocessing. Deterioration in a patientās health should also be treated as a potential safety concern. Device problems should be reported through the applicable organizational and regulatory processes.
Conclusion: Treat printing as a controlled manufacturing process
The practical implication for healthcare organizations is that 3D printing must be managed as more than a design or fabrication activity. Safe use depends on aligning intended use and risk classification with material selection, validated reprocessing, documented production controls, appropriate testing and ongoing monitoring. Involving end-users, technical specialists and medical device reprocessing teams early can help establish whether a proposed device can be made, processed and used safely within the available capabilities.
Access Official Technical PDF